BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24043968)

  • 1. Pretreatment evaluation with contrast-enhanced ultrasonography for percutaneous radiofrequency ablation of hepatocellular carcinomas with poor conspicuity on conventional ultrasonography.
    Kim AY; Lee MW; Rhim H; Cha DI; Choi D; Kim YS; Lim HK; Cho SW
    Korean J Radiol; 2013; 14(5):754-63. PubMed ID: 24043968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced ultrasound-guided radiofrequency ablation in inconspicuous hepatocellular carcinoma on B-mode ultrasound.
    Kim EJ; Kim YS; Shin SK; Kwon OS; Choi DJ; Kim JH
    Turk J Gastroenterol; 2017 Nov; 28(6):446-452. PubMed ID: 29086712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US.
    Min JH; Lim HK; Lim S; Kang TW; Song KD; Choi SY; Rhim H; Lee MW
    Clin Mol Hepatol; 2014 Mar; 20(1):61-70. PubMed ID: 24757660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Planning Sonography Using Real-time Virtual Sonography and Contrast-enhanced Sonography for Radiofrequency Ablation of Inconspicuous Hepatocellular Carcinoma Nodules.
    Toshikuni N; Takuma Y; Tomokuni J; Yamamoto H
    Hepatogastroenterology; 2015 May; 62(139):661-6. PubMed ID: 26897949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging.
    Minami T; Minami Y; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Inoue T; Hagiwara S; Ueshima K; Nishida N; Kudo M
    Oncology; 2014; 87 Suppl 1():55-62. PubMed ID: 25427734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography.
    Park HJ; Lee MW; Rhim H; Cha DI; Kang TW; Lim S; Song KD; Lim HK
    Clin Radiol; 2015 Apr; 70(4):387-94. PubMed ID: 25582889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results.
    Du J; Li HL; Zhai B; Chang S; Li FH
    Ultrasound Med Biol; 2015 Sep; 41(9):2400-11. PubMed ID: 26055968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hepatocellular carcinoma tumor vascularity using contrast-enhanced ultrasonography as a predictor for local recurrence following radiofrequency ablation.
    Ishii T; Numata K; Hao Y; Doba N; Hara K; Kondo M; Tanaka K; Maeda S
    Eur J Radiol; 2017 Apr; 89():234-241. PubMed ID: 28034569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.
    Lee SJ; Won HJ; Kim KW; Shin YM; Kim PN
    J Clin Ultrasound; 2017 Sep; 45(7):383-390. PubMed ID: 28271531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation.
    Chen MH; Yang W; Yan K; Dai Y; Wu W; Fan ZH; Callstrom MR; Charboneau JW
    Clin Radiol; 2007 Aug; 62(8):752-60. PubMed ID: 17604763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
    Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
    J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Contrast-enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma: A Retrospective Study.
    Chan AK; Hegarty C; Klass D; Yoshida E; Chung S; Liu DM; Ho SG; Harris AC
    Can Assoc Radiol J; 2015 May; 66(2):171-8. PubMed ID: 25637354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation for viable hepatocellular carcinoma around retained iodized oil after transcatheter arterial chemoembolization: usefulness of biplane fluoroscopy plus ultrasound guidance.
    Min JH; Lee MW; Rhim H; Choi D; Kim YS; Kim YJ; Cha DI; Lim HK
    Korean J Radiol; 2012; 13(6):784-94. PubMed ID: 23118578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced ultrasonography-CT/MRI fusion guidance for percutaneous ablation of inconspicuous, small liver tumors: improving feasibility and therapeutic outcome.
    Lee Y; Yoon JH; Han S; Joo I; Lee JM
    Cancer Imaging; 2024 Jan; 24(1):4. PubMed ID: 38172949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation combined with chemoembolization for intermediate-sized (3-5 cm) hepatocellular carcinomas under dual guidance of biplane fluoroscopy and ultrasonography.
    Min JH; Lee MW; Cha DI; Jeon YH; Shin SW; Cho SK; Rhim H; Lim HK
    Korean J Radiol; 2013; 14(2):248-58. PubMed ID: 23483753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonography fusion imaging system increases the chance of radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on conventional ultrasonography.
    Makino Y; Imai Y; Ohama H; Igura T; Kogita S; Sawai Y; Fukuda K; Takamura M; Ohashi H; Murakami T
    Oncology; 2013; 84 Suppl 1():44-50. PubMed ID: 23428858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography.
    Rhim H; Choi D; Kim YS; Lim HK; Choe BK
    Eur J Radiol; 2010 Aug; 75(2):253-8. PubMed ID: 19427152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography.
    Lee MW; Rhim H; Cha DI; Kim YJ; Choi D; Kim YS; Lim HK
    AJR Am J Roentgenol; 2012 Jun; 198(6):1438-44. PubMed ID: 22623560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation.
    Kisaka Y; Hirooka M; Kumagi T; Uehara T; Hiasa Y; Kumano S; Tanaka H; Michitaka K; Horiike N; Mochizuki T; Onji M
    Liver Int; 2006 Dec; 26(10):1241-7. PubMed ID: 17105590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.